After several weeks of incredible discussions with our special guests, it’s time that we dive into the medical oncology regarding breast cancer. We start our discussion with the first of our two-part discussion on early stage (AKA non-metastatic) ER+/HER2- breast cancer.
Content:
- What information do we need to consider in patients with HR+ breast cancer?
-What is the role of chemotherapy?
-If chemotherapy is indicated, what are the treatment options? Why?
-Anti-estrogen therapy selection and duration
-Is there a role in ovarian suppression in HR+ disease?
** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes
Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!
Twitter: @TheFellowOnCall
Instagram: @TheFellowOnCall
Listen in on: Apple Podcast, Spotify, and Google Podcast
The Fellow on Call: The Heme/Onc Podcast